LOGIN  |  REGISTER
Amneal Pharmaceuticals
C4 Therapeutics

Alignment Healthcare to Present at Morgan Stanley 23rd Annual Global Healthcare Conference and Baird 2025 Global Healthcare Conference

August 27, 2025 | Last Trade: US$16.36 0.04 0.25

ORANGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) --  Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences in New York:

  • Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept. 9, at 8:30 a.m. EDT
  • Baird 2025 Global Healthcare Conference on Wednesday, Sept. 10, at 12:15 p.m. EDT.

A webcast and replay of the presentations will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/.

About Alignment Healthcare

Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.

Investor Contact
Harrison Zhuo
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact
Priya Shah
mPR, Inc. for Alignment Healthcare
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page